Paweł Mazur, East Area Director of Accord, featured in the Pharma Boardroom and the HCLS Review report on Poland
As East Area Director for the vast CEE market, Paweł Mazur explains how Accord Healthcare Poland
Read More
Newsroom
Fawdon continues to grow and forge closer relationships with the local community
Our Fawdon factory in Newcastle recently welcomed Cllr Ged Bell, from Newcastle City Council and Keith Daniels, Site Head was able to bring him up to date with the latest news from the site.
Read MoreGrowth in the Time of Brexit
Growth in the Time of Brexit: Pharm Exec speaks with our executive VP, Europe & EMENA, James Burt, about the company’s vision for the UK and Europe post-Brexit, the challenges of retaining the company’s culture amid major growth, and the current landscape for generic medicines.
Read MoreMedicines for Europe
As Member of Medicines for Europe, we are happy to support the “Access To Medicines: Better Care for More Patients” campaign.
Read MoreACCORD HEALTHCARE ANNOUNCES EUROPEAN COMMISSION APPROVAL AND COMPLETION OF ITS PURCHASE OF A BASKET OF PRODUCTS FROM TEVA
Accord Healthcare is pleased to announce EC approval has been granted for its purchase of European Economic Area (EEA) rights to a basket of 13 products from TEVA.
Read MoreAccord Healthcare – Agile Supply in a Crowded Market
Following a major acquisition of another leading generic pharmaceutical company, Accord Healthcare looks to continue to supply the generic medicine industry while mitigating the risks that come with acquisitions.
Read MoreAccord Healthcare in the Spotlight of New Statesman magazine, the supplement dedicated to Healthcare
In an article dedicated to the generic medicines and the invaluable role they play, James Burt – Executive Vice-president of Accord Healthcare Europe and MENA – talks about how generics provide better value to taxpayers and better outcomes for the patients.
Read MoreIntas completes deal
Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses.
Read More